Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes

Circulation

Volumn 103, Issue 3, 2001, Pages 369-374

  Sato, Yukihito ^a   Yamada, Tasuku ^a   Taniguchi, Ryoji ^a   Nagai, Kozo ^a   Makiyama, Takeru ^a   Okada, Hideshi ^a   Kataoka, Kazuaki ^b   Ito, Haruyasu ^b   Matsumori, Akira ^b   Sasayama, Shigetake ^b   Takatsu, Yoshiki ^a  

^a HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Cardiomyopathy; Heart failure; Proteins

Indexed keywords

AMLODIPINE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; NITRIC ACID DERIVATIVE; TROPONIN T;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CELL DAMAGE; CONGESTIVE CARDIOMYOPATHY; FEMALE; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; OBSERVER VARIATION; OUTCOMES RESEARCH; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

EID: 0035936510     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.3.369     Document Type: Article

References (31)

1. Idiopathic dilated cardiomyopathy
2. Cardiac troponins: IT upgrade for the heart
3. The troponins
4. Biochemical markers of the acute coronary syndromes
5. Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy
6. Serum concentration of cardiac troponin T in patients with cardiomyopathy: A possible mechanism of acute heart failure
7. Interferon treatment for dilated cardiomyopathy and striated myopathy associated with hepatitis C virus infection based on serial measurements of serum concentrations of cardiac troponin T
8. Measurements of serum concentrations of cardiac troponin T in patients with hypereosinophilic syndrome: A sensitive non-invasive marker of cardiac disorder
9. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
10. Myocarditis: A histopathologic definition and classification
11. Cardiac troponin T composition in normal and regenerating human skeletal muscle
12. Discordance between results for serum troponin T and troponin I in renal disease
13. Multicenter evaluation of a second-generation assay for cardiac troponin T
14. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim
15. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction
16. Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T
17. Diagnostic efficiency of troponin T measurements in acute myocardial infarction
18. Mechanism and significance of myocardial uptake of antimyosis antibody in myocarditis and cardiomyopathy: Clinical and experimental studies
19. Improved troponin T ELISA specific for cardiac troponin T isoform: Assay development and analytical and clinical validation
20. Mechanisms and models in heart failure: A combinatorial approach
21. Pathophysiology of chronic heart failure
22. Treatment of chronic heart failure
23. The pathophysiology of advanced heart failure
24. Why does the myocardium fail? Insights from basic science
25. New targets for heart-failure therapy: Endothelin, inflammatory cytokines, and oxidative stress
26. Viral myocarditis: A paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy
27. The management of chronic heart failure
28. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group
29. Successes and failures of current treatment of heart failure
30. 15 Years of heart-failure trials: What have we learned?
31. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure